Header Logo

Connection

Karl Hansen to Female

Back to Details
This is a "connection" page, showing publications Karl Hansen has written about Female.
Karl Hansen
Connection Strength
1.297
Female
  1. Proprotein Convertase Subtilisin Kexin 9 (PCSK9) and nonHDL particles rise during normal pregnancy and differ by BMI. J Clin Lipidol. 2022 Jul-Aug; 16(4):483-490.
    View in: PubMed
    Score: 0.064
  2. Endometrial scratch to improve outcomes of expectant management in patients with unexplained infertility? Fertil Steril. 2022 03; 117(3):620-621.
    View in: PubMed
    Score: 0.062
  3. Active vs Expectant Management of Persisting Pregnancy of Unknown Location-Reply. JAMA. 2021 12 14; 326(22):2330.
    View in: PubMed
    Score: 0.062
  4. Oil or water-based contrast for hysterosalpingography? Fertil Steril. 2020 07; 114(1):75-76.
    View in: PubMed
    Score: 0.056
  5. Intrauterine insemination performance characteristics and post-processing total motile sperm count in relation to live birth for couples with unexplained infertility in a randomised, multicentre clinical trial. Hum Reprod. 2020 06 01; 35(6):1296-1305.
    View in: PubMed
    Score: 0.056
  6. Luteal-phase progesterone supplementation in non-IVF treatment: a survey of physicians providing infertility treatment. Hum Fertil (Camb). 2020 Dec; 23(4):239-245.
    View in: PubMed
    Score: 0.050
  7. Midluteal Progesterone: A Marker of Treatment Outcomes in Couples With Unexplained Infertility. J Clin Endocrinol Metab. 2018 07 01; 103(7):2743-2751.
    View in: PubMed
    Score: 0.049
  8. The role of steroid hormone supplementation in non-assisted reproductive technology treatments for unexplained infertility. Fertil Steril. 2016 Dec; 106(7):1600-1607.
    View in: PubMed
    Score: 0.043
  9. Time to "cool off"? Examining indications for "elective deferred frozen embryo transfer". J Assist Reprod Genet. 2016 Dec; 33(12):1551-1552.
    View in: PubMed
    Score: 0.043
  10. Predictors of pregnancy and live-birth in couples with unexplained infertility after ovarian stimulation-intrauterine insemination. Fertil Steril. 2016 Jun; 105(6):1575-1583.e2.
    View in: PubMed
    Score: 0.041
  11. Lifestyle factors associated with histologically derived human ovarian non-growing follicle count in reproductive age women. Hum Reprod. 2016 Jan; 31(1):150-7.
    View in: PubMed
    Score: 0.040
  12. On-label and off-label drug use in the treatment of endometriosis. Fertil Steril. 2015 Mar; 103(3):612-25.
    View in: PubMed
    Score: 0.038
  13. In high responding patients undergoing an initial IVF cycle, elevated estradiol on the day of hCG has no effect on live birth rate. Reprod Biol Endocrinol. 2014 Nov 28; 12:119.
    View in: PubMed
    Score: 0.038
  14. Validation of the power model of ovarian nongrowing follicle depletion associated with aging in women. Fertil Steril. 2014 Mar; 101(3):851-6.
    View in: PubMed
    Score: 0.036
  15. Predicting reproductive age with biomarkers of ovarian reserve--how (and what) are we measuring? Semin Reprod Med. 2013 Nov; 31(6):416-26.
    View in: PubMed
    Score: 0.035
  16. Ovarian primordial and nongrowing follicle counts according to the Stages of Reproductive Aging Workshop (STRAW) staging system. Menopause. 2012 Feb; 19(2):164-71.
    View in: PubMed
    Score: 0.031
  17. Correlation of ovarian reserve tests with histologically determined primordial follicle number. Fertil Steril. 2011 Jan; 95(1):170-5.
    View in: PubMed
    Score: 0.028
  18. Counting ovarian follicles is not without its challenges. Fertil Steril. 2008 Apr; 89(4):1028-9; author reply 1029.
    View in: PubMed
    Score: 0.024
  19. A new model of reproductive aging: the decline in ovarian non-growing follicle number from birth to menopause. Hum Reprod. 2008 Mar; 23(3):699-708.
    View in: PubMed
    Score: 0.024
  20. Reproductive ageing and ovarian function: is the early follicular phase FSH rise necessary to maintain adequate secretory function in older ovulatory women? Hum Reprod. 2005 Jan; 20(1):89-95.
    View in: PubMed
    Score: 0.019
  21. Reproductive aging and variability in the ovarian antral follicle count: application in the clinical setting. Fertil Steril. 2003 Sep; 80(3):577-83.
    View in: PubMed
    Score: 0.017
  22. Biomarkers of Stress and Male Fertility. Reprod Sci. 2022 04; 29(4):1262-1270.
    View in: PubMed
    Score: 0.016
  23. A personalized medicine approach to ovulation induction/ovarian stimulation: development of a predictive model and online calculator from level-I evidence. Fertil Steril. 2022 02; 117(2):408-418.
    View in: PubMed
    Score: 0.016
  24. Effects of preconception lifestyle intervention in infertile women with obesity: The FIT-PLESE randomized controlled trial. PLoS Med. 2022 01; 19(1):e1003883.
    View in: PubMed
    Score: 0.016
  25. Sleep Habits of Women With Infertility. J Clin Endocrinol Metab. 2021 10 21; 106(11):e4414-e4426.
    View in: PubMed
    Score: 0.015
  26. Natural vs. programmed cycles for frozen embryo transfer: study protocol for an investigator-initiated, randomized, controlled, multicenter clinical trial. Trials. 2021 Sep 27; 22(1):660.
    View in: PubMed
    Score: 0.015
  27. The relationship of plasma antioxidant levels to semen parameters: the Males, Antioxidants, and Infertility (MOXI) randomized clinical trial. J Assist Reprod Genet. 2021 Nov; 38(11):3005-3013.
    View in: PubMed
    Score: 0.015
  28. Relationship between semen regurgitation and pregnancy rates with intrauterine insemination. Fertil Steril. 2021 12; 116(6):1526-1531.
    View in: PubMed
    Score: 0.015
  29. Effect of an Active vs Expectant Management Strategy on Successful Resolution of Pregnancy Among Patients With a Persisting Pregnancy of Unknown Location: The ACT or NOT Randomized Clinical Trial. JAMA. 2021 08 03; 326(5):390-400.
    View in: PubMed
    Score: 0.015
  30. Metabolic syndrome in obesity: treatment success and adverse pregnancy outcomes with ovulation induction in polycystic ovary syndrome. Am J Obstet Gynecol. 2021 09; 225(3):280.e1-280.e11.
    View in: PubMed
    Score: 0.015
  31. Endometrial thickness after ovarian stimulation with gonadotropin, clomiphene, or letrozole for unexplained infertility, and association with treatment outcomes. Fertil Steril. 2021 01; 115(1):213-220.
    View in: PubMed
    Score: 0.014
  32. Pregnancy registry: three-year follow-up of children conceived from letrozole, clomiphene, or gonadotropins. Fertil Steril. 2020 05; 113(5):1005-1013.
    View in: PubMed
    Score: 0.014
  33. Androgenicity and fertility treatment in women with unexplained infertility. Fertil Steril. 2020 03; 113(3):636-641.
    View in: PubMed
    Score: 0.014
  34. The effect of antioxidants on male factor infertility: the Males, Antioxidants, and Infertility (MOXI) randomized clinical trial. Fertil Steril. 2020 03; 113(3):552-560.e3.
    View in: PubMed
    Score: 0.014
  35. Metformin, rosiglitazone, or both for obese women with polycystic ovary syndrome? Fertil Steril. 2020 01; 113(1):87-88.
    View in: PubMed
    Score: 0.013
  36. Do BRCA1 and BRCA2 gene mutation carriers have a reduced ovarian reserve? Protocol for a prospective observational study. BMJ Open. 2019 11 25; 9(11):e033810.
    View in: PubMed
    Score: 0.013
  37. Association between testosterone, semen parameters, and live birth in men with unexplained infertility in an intrauterine insemination population. Fertil Steril. 2019 06; 111(6):1129-1134.
    View in: PubMed
    Score: 0.013
  38. Lower prevalence of non-cavity-distorting uterine fibroids in patients with polycystic ovary syndrome than in those with unexplained infertility. Fertil Steril. 2019 05; 111(5):1011-1019.e1.
    View in: PubMed
    Score: 0.013
  39. Gestational Weight Gain in Women With Polycystic Ovary Syndrome: A Controlled Study. J Clin Endocrinol Metab. 2018 11 01; 103(11):4315-4323.
    View in: PubMed
    Score: 0.012
  40. Optimal treatment for women with a persisting pregnancy of unknown location, a randomized controlled trial: The ACT-or-NOT trial. Contemp Clin Trials. 2018 10; 73:145-151.
    View in: PubMed
    Score: 0.012
  41. Comparison of sonohysterography to hysterosalpingogram for tubal patency assessment in a multicenter fertility treatment trial among women with polycystic ovary syndrome. J Assist Reprod Genet. 2018 Dec; 35(12):2173-2180.
    View in: PubMed
    Score: 0.012
  42. Major depression, antidepressant use, and male and female fertility. Fertil Steril. 2018 05; 109(5):879-887.
    View in: PubMed
    Score: 0.012
  43. Associations between vitamin D levels and polycystic ovary syndrome phenotypes. Minerva Endocrinol. 2019 Jun; 44(2):176-184.
    View in: PubMed
    Score: 0.012
  44. Racial and Ethnic Differences in Pregnancy Rates Following Intrauterine Insemination with a Focus on American Indians. J Racial Ethn Health Disparities. 2018 10; 5(5):1077-1083.
    View in: PubMed
    Score: 0.012
  45. Sexual function in infertile women with polycystic ovary syndrome and unexplained infertility. Am J Obstet Gynecol. 2017 08; 217(2):191.e1-191.e19.
    View in: PubMed
    Score: 0.011
  46. Racial and ethnic differences in the polycystic ovary syndrome metabolic phenotype. Am J Obstet Gynecol. 2017 05; 216(5):493.e1-493.e13.
    View in: PubMed
    Score: 0.011
  47. Chlamydia trachomatis immunoglobulin G3 seropositivity is a predictor of reproductive outcomes in infertile women with patent fallopian tubes. Fertil Steril. 2015 Dec; 104(6):1522-6.
    View in: PubMed
    Score: 0.010
  48. Letrozole, Gonadotropin, or Clomiphene for Unexplained Infertility. N Engl J Med. 2015 Sep 24; 373(13):1230-40.
    View in: PubMed
    Score: 0.010
  49. Recruitment strategies in two reproductive medicine network infertility trials. Contemp Clin Trials. 2015 Nov; 45(Pt B):196-200.
    View in: PubMed
    Score: 0.010
  50. Predictors of participant retention in infertility treatment trials. Fertil Steril. 2015 Nov; 104(5):1236-43.e1-2.
    View in: PubMed
    Score: 0.010
  51. Identification and replication of prediction models for ovulation, pregnancy and live birth in infertile women with polycystic ovary syndrome. Hum Reprod. 2015 Sep; 30(9):2222-33.
    View in: PubMed
    Score: 0.010
  52. Assessment of multiple intrauterine gestations from ovarian stimulation (AMIGOS) trial: baseline characteristics. Fertil Steril. 2015 Apr; 103(4):962-973.e4.
    View in: PubMed
    Score: 0.010
  53. Ecto-5'-nucleotidase (CD73): genomic cloning and characterization of regions upstream of the translation start site. Adv Exp Med Biol. 1994; 370:689-92.
    View in: PubMed
    Score: 0.009
  54. The use of MRI in the pre-surgical evaluation of patients with androgen insensitivity syndrome. J Pediatr Adolesc Gynecol. 2014 Feb; 27(1):e17-20.
    View in: PubMed
    Score: 0.009
  55. Predictors of pregnancy and live birth after insemination in couples with unexplained or male-factor infertility. Fertil Steril. 2012 Apr; 97(4):959-67.
    View in: PubMed
    Score: 0.008
  56. Estimating human ovarian non-growing follicle number: the application of modern stereology techniques to an old problem. Hum Reprod. 2007 Aug; 22(8):2103-10.
    View in: PubMed
    Score: 0.006
  57. Hydronephrosis in a woman undergoing in vitro fertilization. Urology. 2007 Feb; 69(2):384.e19-20.
    View in: PubMed
    Score: 0.006
  58. Age-related analysis of inhibin A, inhibin B, and activin a relative to the intercycle monotropic follicle-stimulating hormone rise in normal ovulatory women. J Clin Endocrinol Metab. 2004 Jun; 89(6):2977-81.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.